Charge-Reversal Near-Infrared II Polymeric Amphiphiles Enable Efficient Combinatorial Gene and Mild Photothermal
Fang Tang1, Xiaoyu Zhang2, Zhenqi Liu1
1State Key Laboratory of Flexible Electronics (LoFE) & Institute of Flexible Electronics (IFE), Xiamen University, Xiamen 361102, China.
Abstract:
Osteosarcoma (OS) presents formidable challenges due to its aggressive progression and resistance to conventional therapies. Recent advancements in multimodal strategies, such as combining gene therapy with mild-temperature photothermal therapy (mPTT), referred to as GT-mPTT, have shown promise in enhancing therapeutic efficacy while minimizing side effects. However, current systems face limitations in therapeutic response, efficiency, and biosafety. Herein, we report a reactive oxygen species (ROS)-responsive polymeric amphiphile for imaging-guided combinational GT-mPTT therapy, achieving a high-efficiency antitumor performance against OS. This polymer incorporates guanidine-functionalized units for effective gene condensation and near-infrared II (NIR-II) active dyes for efficient photothermal conversion. The system exhibits charge reversal under elevated intratumoral ROS levels, promoting gene release, and achieves controlled mild hyperthermia under NIR-II irradiation, enhancing cellular uptake and enabling effective mPTT. The GT-mPTT combination therapy, guided by dual NIR-II fluorescence and photothermal imaging, demonstrated significant therapeutic outcomes in vitro and in vivo. These include pronounced tumor cell apoptosis, substantial tumor size reduction, and mitigation of osteolysis in OS-bearing mouse models, all while maintaining excellent biosafety and negligible systemic toxicity. This work shows the potential of responsive polymeric platforms with integrated multimodal therapeutic and imaging capabilities as a robust foundation for advancing precision therapies against OS.
Insights
A novel polymer system combines gene therapy with mild photothermal therapy (mPTT) for osteosarcoma (OS). This advanced GT-mPTT approach enhances antitumor efficacy and biosafety, offering a promising new direction for OS treatment.
Area of Science:
- Biomaterials Science
- Oncology
- Nanotechnology
Background:
- Osteosarcoma (OS) is an aggressive bone cancer with limited treatment options.
- Current gene therapy and mild photothermal therapy (mPTT) combinations (GT-mPTT) show promise but face challenges in efficacy and safety.
- There is a need for improved therapeutic strategies to combat OS progression and treatment resistance.
Purpose of the Study:
- To develop a reactive oxygen species (ROS)-responsive polymeric amphiphile for imaging-guided combinational GT-mPTT therapy against OS.
- To enhance therapeutic response, efficiency, and biosafety in OS treatment.
- To create a platform for precision therapy with integrated imaging and treatment capabilities.
Main Methods:
- Synthesized a ROS-responsive polymer incorporating guanidine for gene condensation and NIR-II dyes for photothermal conversion.
- Utilized charge reversal under ROS for controlled gene release and NIR-II irradiation for mild hyperthermia.
- Employed dual NIR-II fluorescence and photothermal imaging for therapy guidance.
- Evaluated GT-mPTT efficacy in vitro and in vivo using OS-bearing mouse models.
Main Results:
- The developed polymer system demonstrated effective gene delivery and controlled mild hyperthermia.
- GT-mPTT therapy significantly enhanced antitumor activity, including increased apoptosis and tumor reduction.
- The treatment successfully mitigated osteolysis in OS mouse models with excellent biosafety and minimal systemic toxicity.
- Dual-modal imaging guided the combination therapy, improving precision and outcomes.
Conclusions:
- The ROS-responsive polymeric platform offers a promising strategy for advanced GT-mPTT in osteosarcoma.
- Integrated imaging and therapeutic functionalities enable precision medicine approaches for OS.
- This work lays the foundation for developing robust and safe multimodal therapies for challenging cancers like OS.
More Related Videos
04:07Author Spotlight: Integrated OPTIR-FISH for Single-Cell Metabolic and Identity Analysis in Complex Environments
Published on: February 23, 2024
06:42Plasmonic Photothermal Cancer Therapy: Nanoparticle-embedded Tumor-tissue-mimicking Phantoms for Visualizing Photothermal Temperature Distribution
Published on: May 9, 2025
Related Concept Videos
Combinatorial Gene Control
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
Gene Therapy
Formal Charges
Ions and Ionic Charges
Atomic Radii and Effective Nuclear Charge
Electric Charges
The English physicist William Gilbert studied the phenomenon of static electricity in...
